当前位置:首页 - 行情中心 - 九安医疗(002432) - 财务分析

九安医疗

(002432)

  

流通市值:175.87亿  总市值:186.52亿
流通股本:4.38亿   总股本:4.65亿

九安医疗(002432)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润9.20亿元,每股收益2.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2203980.79万元,未分配利润1898493.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2865942.62万元,负债661961.83万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入765,265,184.21506,998,641.122,592,196,225.392,092,059,399.68
营业总成本897,862,987.49442,333,724.731,884,214,150.21,411,084,823.28
其他经营收益
营业利润981,091,127.85303,555,606.022,109,802,117.611,817,568,543.94
利润总额981,043,992.75303,501,468.212,106,869,818.061,817,131,659.23
净利润920,175,295.83277,815,657.51,800,042,144.81,533,576,285.11
每股收益
其他综合收益361,186,484.93240,079,618.96696,472,446.46-141,699,686.58
综合收益总额1,281,361,780.76517,895,276.462,496,514,591.261,391,876,598.53
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计15,535,869,391.1814,276,093,278.6814,077,286,222.8914,094,178,779.27
非流动资产:
非流动资产合计13,123,556,839.8312,389,433,264.5312,258,066,152.8710,370,341,483.8
资产总计28,659,426,231.0126,665,526,543.2126,335,352,375.7624,464,520,263.07
流动负债:
流动负债合计4,525,978,981.193,236,458,817.082,560,084,645.181,779,740,199.17
非流动负债:
非流动负债合计2,093,639,356.251,738,453,873.62,284,650,512.992,663,239,744.63
负债合计6,619,618,337.444,974,912,690.684,844,735,158.174,442,979,943.8
所有者权益(或股东权益):
归属于母公司股东权益合计21,774,412,884.0721,421,900,400.8820,736,503,543.7619,272,897,613.9
股东权益合计22,039,807,893.5721,690,613,852.5321,490,617,217.5920,021,540,319.27
负债和股东权益合计28,659,426,231.0126,665,526,543.2126,335,352,375.7624,464,520,263.07
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计888,299,929.66425,532,491.222,797,527,196.322,008,906,458.44
经营活动现金流出小计872,041,227.11418,217,387.371,810,774,325.271,313,825,364.78
经营活动产生的现金流量净额16,258,702.557,315,103.85986,752,871.05695,081,093.66
投资活动产生的现金流量:
投资活动现金流入小计3,645,342,159.432,706,047,730.7915,298,693,624.5112,356,850,329.15
投资活动现金流出小计4,810,337,593.463,137,021,922.0115,879,964,288.7112,709,053,561.28
投资活动产生的现金流量净额-1,164,995,434.03-430,974,191.22-581,270,664.2-352,203,232.13
筹资活动产生的现金流量:
筹资活动现金流入小计3,811,604,717.441,072,866,127.63,998,037,048.792,747,575,908.37
筹资活动现金流出小计3,229,740,383.681,149,266,891.973,901,831,315.423,218,349,904.58
筹资活动产生的现金流量净额581,864,333.76-76,400,764.3796,205,733.37-470,773,996.21
汇率变动对现金及现金等价物的影响-11,002,856.19-5,620,578.1943,938,792.7-30,827,241.11
现金及现金等价物净增加额-577,875,253.91-505,680,429.93545,626,732.92-158,723,375.79
期末现金及现金等价物余额2,257,753,596.612,329,948,420.592,835,628,850.522,131,278,741.81
补充资料:
现金及现金等价物的净增加额-577,875,253.91-545,626,732.92-
最新报告期:2025-09-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟3.844.234.692025-09-15
TOP↑